Review · Not a partner
MEDVi sells compounded semaglutide at $179 for the first month and $299 every month after, which its own FAQ says plainly two screens below the banner.
One month, no commitment
$299/mo, month to month
Price read from MEDVi's own page
Not a partner. Links to MEDVi go to their own site and pay us nothing. Who pays us.
Compare every priced provider →MEDVi is a cash-pay telehealth platform selling compounded GLP-1 medication, and it's the most forthcoming company on this roster about who actually fills the prescription. Three pharmacies are named in its footer with street addresses and phone numbers: Triad Rx in Daphne, Alabama, RedRock Pharmacy in St. George, Utah, and Beaker Pharmacy & Compounding in McKinney, Texas. Most companies here name no pharmacy at all, and almost none of the ones that do give you an address.
The clinical side runs through OpenLoop Health, which MEDVi names in its own footnote. MEDVi says it is not a pharmacy and does not produce compounded medication — a distinction worth reading twice, because it is also the distinction at the center of the warning letter below.
| Plan | Per month | Charged today |
|---|---|---|
Refills, month to monthSourceThe MEDVi Semaglutide program starts at $179 for your first month with no contract. This cost covers your physician review, full personalized plan, 1:1 guidance, metabolic report, and the cost of the prescription medication shipped right to your door. Refills are locked in at $299 and include all the same program benefits.https://glp1.medvi.org/ — read 2026-09-02 | $299 | $299 |
One price at every dose is promised nowhere we read. The $299 is described as a locked refill rate covering the medication and the program together: “Medication is included in the cost of the MEDVi Program.”
$179 buys the first month. $299 buys every month after that, and MEDVi says so itself in the FAQ at the bottom of the same page the $179 banner sits on top of: the program “starts at $179 for your first month with no contract”, and “Refills are locked in at $299 and include all the same program benefits.” We publish the $299, because that's the number you live with.
Then there's the membership question, and here the page argues with itself. The hero reads “No membership or hidden fees! Everything you need is included”. Three of the five product cards immediately beneath it read “$99 Membership + Medication Cost” — for the Wegovy pill, the Wegovy injection and the Zepbound injection. Both statements sat on one page on one day. The reading that reconciles them is that the compounded programs carry no membership and the brand ones do, but the page never says that, and the promise is not qualified.
The dissolvable tablets are advertised at “Starting at $249”. What a refill costs isn't printed. That matters more here than it usually would, because the injection's “Starting at $179” turned out to mean month one, and the FAQ that explains it covers the Semaglutide program only. The brand medications are thinner still: the card gives you the $99 membership and calls the rest “Medication Cost”, which is not a price.
Cancel at least 72 hours before the next billing date or you're charged for another cycle. On a monthly plan there's no refund at all for the month you cancel in — MEDVi's refund policy says so in capitals — and none for prior months. The exceptions are narrow and clearly written: a full refund inside the first 72 hours if you've received nothing, and a full refund if a provider disqualifies you.
The full breakdown — what is included, what is extra, and what happens at higher doses — is on the MEDVi cost page.
Anyone budgeting from the banner. The gap between $179 and $299 is $120, it arrives in month two, and it is two thirds more than the figure you signed up on.
Anyone who wants a brand drug priced before they start. “$99 Membership + Medication Cost” gives you one of the two numbers you need.
Anyone who might change their mind in week three. A monthly plan refunds nothing for the month you cancel in, and the notice has to land 72 hours before the billing date.
These are the checks this site applies to every company — how we review. Not stated means we could not find it on their site, which is a finding about the site, not about the company.
The sentence that sets the real price, quoted in full from the FAQ on https://glp1.medvi.org/, read September 2, 2026: “How much does the program cost? The MEDVi Semaglutide program starts at $179 for your first month with no contract. This cost covers your physician review, full personalized plan, 1:1 guidance, metabolic report, and the cost of the prescription medication shipped right to your door. Refills are locked in at $299 and include all the same program benefits.”
Read September 2, 2026 across four of MEDVi's own pages: home.medvi.org, glp1.medvi.org, the cancellation and refund policy and the terms and conditions. Every figure here appears in the visible text of one of them.
The five product cards on glp1.medvi.org, transcribed in order: “Starting at $179 GLP-1 Injections One simple injection per week.” · “Starting at $249 GLP-1 Tablets One dissolvable tablet per day.” · “$99 Membership + Medication Cost Wegovy® Pill One pill per day.” · “$99 Membership + Medication Cost Wegovy® Injection Availability is subject to change.” · “$99 Membership + Medication Cost Zepbound® Injection Availability is subject to change.”
The membership contradiction, both halves read on glp1.medvi.org on the same day. The hero: “No membership or hidden fees! Everything you need is included”. The cards, three of five: “$99 Membership + Medication Cost”. We print both rather than pick one.
Which molecule you are buying, censused over the four pages read. “Semaglutide” appears once, in the FAQ answer that prices the program. “Tirzepatide” appears zero times. The injection card says “GLP-1 Injections” and the tablet card says “GLP-1 Tablets”, so only the injection program is tied to a named molecule, and only in the FAQ.
The pharmacies, quoted from the footer that appears on all three public pages we read: “Partner pharmacies include: Triad Rx https://www.triadrx.us Address: 26258 Pollard Rd, Daphne, AL 36526 Phone: (251) 380-7630 RedRock Pharmacy https://www.redrockhomepharmacy.com/ Address: 1240 E 100 S #220, St. George, UT 84790 Phone: (435) 703-2900 Beaker Pharmacy & Compounding https://beakerpharmacy.com/beakerpharmacy-compounding Address: 7810 Eldorado Pkwy STE 200, McKinney, TX 75072 Phone: (972) 972-4700”. The same footer states: “Compound medications are dispensed by state-licensed pharmacies but are not FDA approved.”
The refund terms, quoted from home.medvi.org/cancellation-and-refund-policy: “we require your cancellation request to be received at least 72 hours prior to your next billing date”; “If your Subscription Service is charged monthly, YOU WILL NOT BE ISSUED A REFUND UPON CANCELLATION FOR THE MONTH IN WHICH THE CANCELLATION OCCURRED OR FOR ANY PRIOR MONTHS.”; “If your Subscription Service is cancelled by notifying patient support at hello@medvi.org within the first 72 hours of your Subscription term and you have not received any Subscription Services, you will be issued a full refund.”; and “if you are disqualified by our healthcare provider for a medical reason you will receive a full refund.”
FDA warning letter 721455, issued February 20, 2026, category “False & Misleading Claims/Misbranded (Telehealth)”. We matched it on entity and address rather than on the brand name: the letter is addressed to “MEDVi, LLC dba MEDVi, 131 Continental Dr, Ste 305, Newark, DE 19713”, which is the address printed in the footer of the page we read. Two things about it are worth stating precisely. FDA says it “reviewed your website content at the internet address https://medvi.io, in December 2025” — a different top-level domain from the medvi.org we read, and nine months ago. And the allegations are about labeling and claims, not about the medicine: that the products displayed “identify “MEDVi” on the pictured label, suggesting MEDVi is the compounder of those drugs when in fact it is not”, and that two claims, “Same active ingredient as Wegovy® and Ozempic®.” and “Same active ingredient as Mounjaro® and Zepbound®.”, imply an FDA approval compounded products do not have. The letter states no action that halted the business; its only enforcement language is prospective. A warning letter discloses, and this site treats it that way: MEDVi is listed, linked and priced exactly like everyone else here.
What we did not find, and where we looked. Across home.medvi.org, glp1.medvi.org, the refund policy and the terms, read September 2, 2026, we searched for a statement that prescribers are licensed in the patient's own state and for any mention of overseas or international fulfillment. The phrase “licensed in” does not occur on any of the four; the closest statement is “Prescriptions are issued only after an online consultation with an independent licensed provider.” Nothing on those pages addresses where medication ships from.
The same molecules at every other company we have reviewed, with the range each one falls in.
MEDVi's record is one of the inputs to these pieces, so a correction here moves their numbers too.
Words used above: Compounded, Membership, Overseas fulfillment. All of them are in the glossary.
Not a partner. This link goes to MEDVi and pays us nothing. Who pays us.
Every company we have reviewed is on the reviews index. See who writes these reviews. Your privacy choices and the terms of use apply to this page.